Cencora, Inc. logo
Cencora, Inc. (COR)
Compare

Cencora, Inc. (COR) Free Cash Flow (FCF): $1.56B

The free cash flow (FCF) for Cencora, Inc. (COR) is $1.56B. It is below its 12-month average by 49.78% ($3.10B).

COR Free Cash Flow (FCF) Chart

COR Free Cash Flow (FCF)
$3.21B+6.99% 1Y
Zoom

COR Average Free Cash Flow (FCF) Chart

COR Current vs Average Free Cash Flow (FCF) Chart

COR Free Cash Flow (FCF) Metrics

FREE CASH FLOW (FCF)

$1.56B

FREE CASH FLOW (FCF) AVG TTM

$3.10B

FREE CASH FLOW (FCF) AVG 3Y

$2.97B

FREE CASH FLOW (FCF) AVG 5Y

$2.66B

FREE CASH FLOW (FCF) AVG 10Y

$2.41B

FREE CASH FLOW (FCF) AVG 15Y

$1.96B

FREE CASH FLOW (FCF) AVG 20Y

$1.70B

CURRENT VS TTM AVG

-49.78%

CURRENT VS 3Y AVG

-47.47%

CURRENT VS 5Y AVG

-41.31%

CURRENT VS 10Y AVG

-35.24%

CURRENT VS 15Y AVG

-20.39%

CURRENT VS 20Y AVG

-8.24%

FCF Analysis

Free Cash Flow (TTM)

$1.56B

FCF Yield

2.83%

Price/FCF

35.3

Formula: FCF = Operating Cash Flow - Capital Expenditures

Why FCF matters:

  • Shows actual cash available (not accounting earnings)
  • Funds dividends, buybacks, and debt reduction
  • Less susceptible to accounting manipulation than net income
  • Key metric for DCF valuation models

Cencora, Inc. Free Cash Flow (FCF) Formula & Definition

Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Cencora, Inc. Free Cash Flow (FCF) FAQ

What is the free cash flow (FCF) for Cencora, Inc. (COR)?
The free cash flow (FCF) for COR stock is $1.56B.
What is the TTM average free cash flow (FCF) for Cencora, Inc. (COR)?
The TTM average free cash flow (FCF) for COR stock is $3.10B.
What is the 3Y average free cash flow (FCF) for Cencora, Inc. (COR)?
The 3Y average free cash flow (FCF) for COR stock is $2.97B.
What is the 5Y average free cash flow (FCF) for Cencora, Inc. (COR)?
The 5Y average free cash flow (FCF) for COR stock is $2.66B.
What is the 10Y average free cash flow (FCF) for Cencora, Inc. (COR)?
The 10Y average free cash flow (FCF) for COR stock is $2.41B.
What is the 15Y average free cash flow (FCF) for Cencora, Inc. (COR)?
The 15Y average free cash flow (FCF) for COR stock is $1.96B.
What is the 20Y average free cash flow (FCF) for Cencora, Inc. (COR)?
The 20Y average free cash flow (FCF) for COR stock is $1.70B.

Cencora, Inc. Free Cash Flow (FCF) History

DATEFREE CASH FLOW (FCF)
2025-09-30$3.21B
2024-09-30$3.00B
2023-09-30$3.45B
2022-09-30$2.21B
2021-09-30$2.23B
2020-09-30$1.84B
2019-09-30$2.03B
2018-09-30$1.07B
2017-09-30$1.02B
2016-09-30$2.71B
2015-09-30$3.69B
2014-09-30$1.20B
2013-09-30$585.67M
2012-09-30$1.14B
2011-09-30$999.99M
2010-09-30$923.99M
2009-09-30$637.93M
2008-09-30$599.76M
2007-09-30$1.09B
2006-09-30$694.13M
2005-09-30$1.32B
2004-09-30$635.80M
2003-09-30$264.26M
2002-09-30$471.77M
2001-09-30$-63.37M
2000-09-30$199.96M
1999-09-30$-12.80M
1998-09-30$115.50M
1997-09-30$-25.20M
1996-09-30$24.30M

About Cencora, Inc.

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.

Conshohocken, PA
47,000 employees
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Robert Mauch